https://www.selleckchem.com/pr....oducts/gsk3368715.ht
This scientific statement is endorsed by European Academy of Neurology (EAN). This article is protected by copyright. All rights reserved.BACKGROUND AND PURPOSE Cancer is a frequent finding in ischaemic stroke patients. The frequency of cancer amongst participants in the NAVIGATE ESUS randomized trial and the distribution of outcome events during treatment with aspirin and rivaroxaban were investigated. METHODS Trial participation required a recent embolic stroke of undetermined source. Patients' history of cancer was recorded at the
پسندیدن
اظهار نظر
اشتراک گذاری
